Global Chronic Hepatitis B Virus Testing Market Growth 2026-2032

August 2026 | 114 pages | ID: GB7A412ED8D1EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Chronic Hepatitis B Virus Testing market size is predicted to grow from US$ 1014 million in 2025 to US$ 1631 million in 2032; it is expected to grow at a CAGR of 7.2% from 2026 to 2032.

Chronic Hepatitis B Virus (HBV) testing refers to a series of laboratory tests that detect the presence of the virus in the blood over an extended period. Chronic hepatitis B is a condition in which the HBV infection lasts for more than six months.

United States market for Chronic Hepatitis B Virus Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Chronic Hepatitis B Virus Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Chronic Hepatitis B Virus Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Chronic Hepatitis B Virus Testing players cover Gilead Sciences, GlaxoSmithKline, Ionis Pharma, Janssen Sciences Ireland, Assembly Biosciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Chronic Hepatitis B Virus Testing Industry Forecast” looks at past sales and reviews total world Chronic Hepatitis B Virus Testing sales in 2025, providing a comprehensive analysis by region and market sector of projected Chronic Hepatitis B Virus Testing sales for 2026 through 2032. With Chronic Hepatitis B Virus Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chronic Hepatitis B Virus Testing industry.

This Insight Report provides a comprehensive analysis of the global Chronic Hepatitis B Virus Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chronic Hepatitis B Virus Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chronic Hepatitis B Virus Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chronic Hepatitis B Virus Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chronic Hepatitis B Virus Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Chronic Hepatitis B Virus Testing market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Enzyme Immunoassay Kits
  • Hepatitis B Surface Antigen Test
  • Anti-Hepatitis B Surface Antibody Test
  • Anti-Hepatitis B Core Antibody Test
  • Point-of-Care Testing Kits
Segmentation by Application:
  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Home
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Gilead Sciences
  • GlaxoSmithKline
  • Ionis Pharma
  • Janssen Sciences Ireland
  • Assembly Biosciences
  • Janssen and Arrowhead Pharmaceuticals
  • Roche
  • Vir Biotechnology
  • Bio-Rad Laboratories, Inc.
  • DiaSorin S.p.A.
  • Abbott Laboratories
  • Meridian Bioscience
Key Questions Addressed in this Report
  • What is the 10-year outlook for the global Chronic Hepatitis B Virus Testing market?
  • What factors are driving Chronic Hepatitis B Virus Testing market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Chronic Hepatitis B Virus Testing market opportunities vary by end market size?
  • How does Chronic Hepatitis B Virus Testing break out by Type, by Application?
1 SCOPE OF THE REPORT

  1.1 Market Introduction
  1.2 Years Considered
  1.3 Research Objectives
  1.4 Market Research Methodology
  1.5 Research Process and Data Source
  1.6 Economic Indicators
  1.7 Currency Considered
  1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

  2.1 World Market Overview
  2.1.1 Global Chronic Hepatitis B Virus Testing Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Chronic Hepatitis B Virus Testing by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Chronic Hepatitis B Virus Testing by Country/Region, 2021, 2025 & 2032
  2.2 Chronic Hepatitis B Virus Testing Segment by Type
  2.2.1 Enzyme Immunoassay Kits
  2.2.2 Hepatitis B Surface Antigen Test
  2.2.3 Anti-Hepatitis B Surface Antibody Test
  2.2.4 Anti-Hepatitis B Core Antibody Test
  2.2.5 Point-of-Care Testing Kits
  2.2.6 Chronic Hepatitis B Virus Testing Sales by Type
  2.2.6.1 Global Chronic Hepatitis B Virus Testing Sales Market Share by Type (2021-2026)
  2.2.6.2 Global Chronic Hepatitis B Virus Testing Revenue and Market Share by Type (2021-2026)
  2.2.6.3 Global Chronic Hepatitis B Virus Testing Sale Price by Type (2021-2026)
  2.3 Chronic Hepatitis B Virus Testing Segment by Application
  2.3.1 Hospitals
  2.3.2 Clinics
  2.3.3 Diagnostic Centers
  2.3.4 Home
  2.3.5 Chronic Hepatitis B Virus Testing Sales by Application
  2.3.5.1 Global Chronic Hepatitis B Virus Testing Sale Market Share by Application (2021-2026)
  2.3.5.2 Global Chronic Hepatitis B Virus Testing Revenue and Market Share by Application (2021-2026)
  2.3.5.3 Global Chronic Hepatitis B Virus Testing Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

  3.1 Global Chronic Hepatitis B Virus Testing Breakdown Data by Company
  3.1.1 Global Chronic Hepatitis B Virus Testing Annual Sales by Company (2021-2026)
  3.1.2 Global Chronic Hepatitis B Virus Testing Sales Market Share by Company (2021-2026)
  3.2 Global Chronic Hepatitis B Virus Testing Annual Revenue by Company (2021-2026)
  3.2.1 Global Chronic Hepatitis B Virus Testing Revenue by Company (2021-2026)
  3.2.2 Global Chronic Hepatitis B Virus Testing Revenue Market Share by Company (2021-2026)
  3.3 Global Chronic Hepatitis B Virus Testing Sale Price by Company
  3.4 Key Manufacturers Chronic Hepatitis B Virus Testing Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Chronic Hepatitis B Virus Testing Product Location Distribution
  3.4.2 Players Chronic Hepatitis B Virus Testing Products Offered
  3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
  3.6 New Products and Potential Entrants
  3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR CHRONIC HEPATITIS B VIRUS TESTING BY GEOGRAPHIC REGION

  4.1 World Historic Chronic Hepatitis B Virus Testing Market Size by Geographic Region (2021-2026)
  4.1.1 Global Chronic Hepatitis B Virus Testing Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Chronic Hepatitis B Virus Testing Annual Revenue by Geographic Region (2021-2026)
  4.2 World Historic Chronic Hepatitis B Virus Testing Market Size by Country/Region (2021-2026)
  4.2.1 Global Chronic Hepatitis B Virus Testing Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Chronic Hepatitis B Virus Testing Annual Revenue by Country/Region (2021-2026)
  4.3 Americas Chronic Hepatitis B Virus Testing Sales Growth
  4.4 APAC Chronic Hepatitis B Virus Testing Sales Growth
  4.5 Europe Chronic Hepatitis B Virus Testing Sales Growth
  4.6 Middle East & Africa Chronic Hepatitis B Virus Testing Sales Growth

5 AMERICAS

  5.1 Americas Chronic Hepatitis B Virus Testing Sales by Country
  5.1.1 Americas Chronic Hepatitis B Virus Testing Sales by Country (2021-2026)
  5.1.2 Americas Chronic Hepatitis B Virus Testing Revenue by Country (2021-2026)
  5.2 Americas Chronic Hepatitis B Virus Testing Sales by Type (2021-2026)
  5.3 Americas Chronic Hepatitis B Virus Testing Sales by Application (2021-2026)
  5.4 United States
  5.5 Canada
  5.6 Mexico
  5.7 Brazil

6 APAC

  6.1 APAC Chronic Hepatitis B Virus Testing Sales by Region
  6.1.1 APAC Chronic Hepatitis B Virus Testing Sales by Region (2021-2026)
  6.1.2 APAC Chronic Hepatitis B Virus Testing Revenue by Region (2021-2026)
  6.2 APAC Chronic Hepatitis B Virus Testing Sales by Type (2021-2026)
  6.3 APAC Chronic Hepatitis B Virus Testing Sales by Application (2021-2026)
  6.4 China
  6.5 Japan
  6.6 South Korea
  6.7 Southeast Asia
  6.8 India
  6.9 Australia
  6.10 China Taiwan

7 EUROPE

  7.1 Europe Chronic Hepatitis B Virus Testing by Country
  7.1.1 Europe Chronic Hepatitis B Virus Testing Sales by Country (2021-2026)
  7.1.2 Europe Chronic Hepatitis B Virus Testing Revenue by Country (2021-2026)
  7.2 Europe Chronic Hepatitis B Virus Testing Sales by Type (2021-2026)
  7.3 Europe Chronic Hepatitis B Virus Testing Sales by Application (2021-2026)
  7.4 Germany
  7.5 France
  7.6 UK
  7.7 Italy
  7.8 Russia

8 MIDDLE EAST & AFRICA

  8.1 Middle East & Africa Chronic Hepatitis B Virus Testing by Country
  8.1.1 Middle East & Africa Chronic Hepatitis B Virus Testing Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Chronic Hepatitis B Virus Testing Revenue by Country (2021-2026)
  8.2 Middle East & Africa Chronic Hepatitis B Virus Testing Sales by Type (2021-2026)
  8.3 Middle East & Africa Chronic Hepatitis B Virus Testing Sales by Application (2021-2026)
  8.4 Egypt
  8.5 South Africa
  8.6 Israel
  8.7 Turkey
  8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

  9.1 Market Drivers & Growth Opportunities
  9.2 Market Challenges & Risks
  9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

  10.1 Raw Material and Suppliers
  10.2 Manufacturing Cost Structure Analysis of Chronic Hepatitis B Virus Testing
  10.3 Manufacturing Process Analysis of Chronic Hepatitis B Virus Testing
  10.4 Industry Chain Structure of Chronic Hepatitis B Virus Testing

11 MARKETING, DISTRIBUTORS AND CUSTOMER

  11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
  11.2 Chronic Hepatitis B Virus Testing Distributors
  11.3 Chronic Hepatitis B Virus Testing Customer

12 WORLD FORECAST REVIEW FOR CHRONIC HEPATITIS B VIRUS TESTING BY GEOGRAPHIC REGION

  12.1 Global Chronic Hepatitis B Virus Testing Market Size Forecast by Region
  12.1.1 Global Chronic Hepatitis B Virus Testing Forecast by Region (2027-2032)
  12.1.2 Global Chronic Hepatitis B Virus Testing Annual Revenue Forecast by Region (2027-2032)
  12.2 Americas Forecast by Country (2027-2032)
  12.3 APAC Forecast by Region (2027-2032)
  12.4 Europe Forecast by Country (2027-2032)
  12.5 Middle East & Africa Forecast by Country (2027-2032)
  12.6 Global Chronic Hepatitis B Virus Testing Forecast by Type (2027-2032)
  12.7 Global Chronic Hepatitis B Virus Testing Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

  13.1 Gilead Sciences
  13.1.1 Gilead Sciences Company Information
  13.1.2 Gilead Sciences Chronic Hepatitis B Virus Testing Product Portfolios and Specifications
  13.1.3 Gilead Sciences Chronic Hepatitis B Virus Testing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Gilead Sciences Main Business Overview
  13.1.5 Gilead Sciences Latest Developments
  13.2 GlaxoSmithKline
  13.2.1 GlaxoSmithKline Company Information
  13.2.2 GlaxoSmithKline Chronic Hepatitis B Virus Testing Product Portfolios and Specifications
  13.2.3 GlaxoSmithKline Chronic Hepatitis B Virus Testing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 GlaxoSmithKline Main Business Overview
  13.2.5 GlaxoSmithKline Latest Developments
  13.3 Ionis Pharma
  13.3.1 Ionis Pharma Company Information
  13.3.2 Ionis Pharma Chronic Hepatitis B Virus Testing Product Portfolios and Specifications
  13.3.3 Ionis Pharma Chronic Hepatitis B Virus Testing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Ionis Pharma Main Business Overview
  13.3.5 Ionis Pharma Latest Developments
  13.4 Janssen Sciences Ireland
  13.4.1 Janssen Sciences Ireland Company Information
  13.4.2 Janssen Sciences Ireland Chronic Hepatitis B Virus Testing Product Portfolios and Specifications
  13.4.3 Janssen Sciences Ireland Chronic Hepatitis B Virus Testing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Janssen Sciences Ireland Main Business Overview
  13.4.5 Janssen Sciences Ireland Latest Developments
  13.5 Assembly Biosciences
  13.5.1 Assembly Biosciences Company Information
  13.5.2 Assembly Biosciences Chronic Hepatitis B Virus Testing Product Portfolios and Specifications
  13.5.3 Assembly Biosciences Chronic Hepatitis B Virus Testing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Assembly Biosciences Main Business Overview
  13.5.5 Assembly Biosciences Latest Developments
  13.6 Janssen and Arrowhead Pharmaceuticals
  13.6.1 Janssen and Arrowhead Pharmaceuticals Company Information
  13.6.2 Janssen and Arrowhead Pharmaceuticals Chronic Hepatitis B Virus Testing Product Portfolios and Specifications
  13.6.3 Janssen and Arrowhead Pharmaceuticals Chronic Hepatitis B Virus Testing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Janssen and Arrowhead Pharmaceuticals Main Business Overview
  13.6.5 Janssen and Arrowhead Pharmaceuticals Latest Developments
  13.7 Roche
  13.7.1 Roche Company Information
  13.7.2 Roche Chronic Hepatitis B Virus Testing Product Portfolios and Specifications
  13.7.3 Roche Chronic Hepatitis B Virus Testing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Roche Main Business Overview
  13.7.5 Roche Latest Developments
  13.8 Vir Biotechnology
  13.8.1 Vir Biotechnology Company Information
  13.8.2 Vir Biotechnology Chronic Hepatitis B Virus Testing Product Portfolios and Specifications
  13.8.3 Vir Biotechnology Chronic Hepatitis B Virus Testing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Vir Biotechnology Main Business Overview
  13.8.5 Vir Biotechnology Latest Developments
  13.9 Bio-Rad Laboratories, Inc.
  13.9.1 Bio-Rad Laboratories, Inc. Company Information
  13.9.2 Bio-Rad Laboratories, Inc. Chronic Hepatitis B Virus Testing Product Portfolios and Specifications
  13.9.3 Bio-Rad Laboratories, Inc. Chronic Hepatitis B Virus Testing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Bio-Rad Laboratories, Inc. Main Business Overview
  13.9.5 Bio-Rad Laboratories, Inc. Latest Developments
  13.10 DiaSorin S.p.A.
  13.10.1 DiaSorin S.p.A. Company Information
  13.10.2 DiaSorin S.p.A. Chronic Hepatitis B Virus Testing Product Portfolios and Specifications
  13.10.3 DiaSorin S.p.A. Chronic Hepatitis B Virus Testing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 DiaSorin S.p.A. Main Business Overview
  13.10.5 DiaSorin S.p.A. Latest Developments
  13.11 Abbott Laboratories
  13.11.1 Abbott Laboratories Company Information
  13.11.2 Abbott Laboratories Chronic Hepatitis B Virus Testing Product Portfolios and Specifications
  13.11.3 Abbott Laboratories Chronic Hepatitis B Virus Testing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 Abbott Laboratories Main Business Overview
  13.11.5 Abbott Laboratories Latest Developments
  13.12 Meridian Bioscience
  13.12.1 Meridian Bioscience Company Information
  13.12.2 Meridian Bioscience Chronic Hepatitis B Virus Testing Product Portfolios and Specifications
  13.12.3 Meridian Bioscience Chronic Hepatitis B Virus Testing Sales, Revenue, Price and Gross Margin (2021-2026)
  13.12.4 Meridian Bioscience Main Business Overview
  13.12.5 Meridian Bioscience Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Chronic Hepatitis B Virus Testing Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Chronic Hepatitis B Virus Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Enzyme Immunoassay Kits
Table 4. Major Players of Hepatitis B Surface Antigen Test
Table 5. Major Players of Anti-Hepatitis B Surface Antibody Test
Table 6. Major Players of Anti-Hepatitis B Core Antibody Test
Table 7. Major Players of Point-of-Care Testing Kits
Table 8. Global Chronic Hepatitis B Virus Testing Sales by Type (2021-2026) & (K Units)
Table 9. Global Chronic Hepatitis B Virus Testing Sales Market Share by Type (2021-2026)
Table 10. Global Chronic Hepatitis B Virus Testing Revenue by Type (2021-2026) & ($ million)
Table 11. Global Chronic Hepatitis B Virus Testing Revenue Market Share by Type (2021-2026)
Table 12. Global Chronic Hepatitis B Virus Testing Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Chronic Hepatitis B Virus Testing Sale by Application (2021-2026) & (K Units)
Table 14. Global Chronic Hepatitis B Virus Testing Sale Market Share by Application (2021-2026)
Table 15. Global Chronic Hepatitis B Virus Testing Revenue by Application (2021-2026) & ($ million)
Table 16. Global Chronic Hepatitis B Virus Testing Revenue Market Share by Application (2021-2026)
Table 17. Global Chronic Hepatitis B Virus Testing Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Chronic Hepatitis B Virus Testing Sales by Company (2021-2026) & (K Units)
Table 19. Global Chronic Hepatitis B Virus Testing Sales Market Share by Company (2021-2026)
Table 20. Global Chronic Hepatitis B Virus Testing Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Chronic Hepatitis B Virus Testing Revenue Market Share by Company (2021-2026)
Table 22. Global Chronic Hepatitis B Virus Testing Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Chronic Hepatitis B Virus Testing Producing Area Distribution and Sales Area
Table 24. Players Chronic Hepatitis B Virus Testing Products Offered
Table 25. Chronic Hepatitis B Virus Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Chronic Hepatitis B Virus Testing Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Chronic Hepatitis B Virus Testing Sales Market Share Geographic Region (2021-2026)
Table 30. Global Chronic Hepatitis B Virus Testing Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Chronic Hepatitis B Virus Testing Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Chronic Hepatitis B Virus Testing Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Chronic Hepatitis B Virus Testing Sales Market Share by Country/Region (2021-2026)
Table 34. Global Chronic Hepatitis B Virus Testing Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Chronic Hepatitis B Virus Testing Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Chronic Hepatitis B Virus Testing Sales by Country (2021-2026) & (K Units)
Table 37. Americas Chronic Hepatitis B Virus Testing Sales Market Share by Country (2021-2026)
Table 38. Americas Chronic Hepatitis B Virus Testing Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Chronic Hepatitis B Virus Testing Sales by Type (2021-2026) & (K Units)
Table 40. Americas Chronic Hepatitis B Virus Testing Sales by Application (2021-2026) & (K Units)
Table 41. APAC Chronic Hepatitis B Virus Testing Sales by Region (2021-2026) & (K Units)
Table 42. APAC Chronic Hepatitis B Virus Testing Sales Market Share by Region (2021-2026)
Table 43. APAC Chronic Hepatitis B Virus Testing Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Chronic Hepatitis B Virus Testing Sales by Type (2021-2026) & (K Units)
Table 45. APAC Chronic Hepatitis B Virus Testing Sales by Application (2021-2026) & (K Units)
Table 46. Europe Chronic Hepatitis B Virus Testing Sales by Country (2021-2026) & (K Units)
Table 47. Europe Chronic Hepatitis B Virus Testing Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Chronic Hepatitis B Virus Testing Sales by Type (2021-2026) & (K Units)
Table 49. Europe Chronic Hepatitis B Virus Testing Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Chronic Hepatitis B Virus Testing Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Chronic Hepatitis B Virus Testing Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Chronic Hepatitis B Virus Testing Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Chronic Hepatitis B Virus Testing Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Chronic Hepatitis B Virus Testing
Table 55. Key Market Challenges & Risks of Chronic Hepatitis B Virus Testing
Table 56. Key Industry Trends of Chronic Hepatitis B Virus Testing
Table 57. Chronic Hepatitis B Virus Testing Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Chronic Hepatitis B Virus Testing Distributors List
Table 60. Chronic Hepatitis B Virus Testing Customer List
Table 61. Global Chronic Hepatitis B Virus Testing Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Chronic Hepatitis B Virus Testing Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Chronic Hepatitis B Virus Testing Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Chronic Hepatitis B Virus Testing Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Chronic Hepatitis B Virus Testing Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Chronic Hepatitis B Virus Testing Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Chronic Hepatitis B Virus Testing Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Chronic Hepatitis B Virus Testing Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Chronic Hepatitis B Virus Testing Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Chronic Hepatitis B Virus Testing Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Chronic Hepatitis B Virus Testing Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Chronic Hepatitis B Virus Testing Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Chronic Hepatitis B Virus Testing Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Chronic Hepatitis B Virus Testing Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Gilead Sciences Basic Information, Chronic Hepatitis B Virus Testing Manufacturing Base, Sales Area and Its Competitors
Table 76. Gilead Sciences Chronic Hepatitis B Virus Testing Product Portfolios and Specifications
Table 77. Gilead Sciences Chronic Hepatitis B Virus Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Gilead Sciences Main Business
Table 79. Gilead Sciences Latest Developments
Table 80. GlaxoSmithKline Basic Information, Chronic Hepatitis B Virus Testing Manufacturing Base, Sales Area and Its Competitors
Table 81. GlaxoSmithKline Chronic Hepatitis B Virus Testing Product Portfolios and Specifications
Table 82. GlaxoSmithKline Chronic Hepatitis B Virus Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. GlaxoSmithKline Main Business
Table 84. GlaxoSmithKline Latest Developments
Table 85. Ionis Pharma Basic Information, Chronic Hepatitis B Virus Testing Manufacturing Base, Sales Area and Its Competitors
Table 86. Ionis Pharma Chronic Hepatitis B Virus Testing Product Portfolios and Specifications
Table 87. Ionis Pharma Chronic Hepatitis B Virus Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Ionis Pharma Main Business
Table 89. Ionis Pharma Latest Developments
Table 90. Janssen Sciences Ireland Basic Information, Chronic Hepatitis B Virus Testing Manufacturing Base, Sales Area and Its Competitors
Table 91. Janssen Sciences Ireland Chronic Hepatitis B Virus Testing Product Portfolios and Specifications
Table 92. Janssen Sciences Ireland Chronic Hepatitis B Virus Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Janssen Sciences Ireland Main Business
Table 94. Janssen Sciences Ireland Latest Developments
Table 95. Assembly Biosciences Basic Information, Chronic Hepatitis B Virus Testing Manufacturing Base, Sales Area and Its Competitors
Table 96. Assembly Biosciences Chronic Hepatitis B Virus Testing Product Portfolios and Specifications
Table 97. Assembly Biosciences Chronic Hepatitis B Virus Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Assembly Biosciences Main Business
Table 99. Assembly Biosciences Latest Developments
Table 100. Janssen and Arrowhead Pharmaceuticals Basic Information, Chronic Hepatitis B Virus Testing Manufacturing Base, Sales Area and Its Competitors
Table 101. Janssen and Arrowhead Pharmaceuticals Chronic Hepatitis B Virus Testing Product Portfolios and Specifications
Table 102. Janssen and Arrowhead Pharmaceuticals Chronic Hepatitis B Virus Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Janssen and Arrowhead Pharmaceuticals Main Business
Table 104. Janssen and Arrowhead Pharmaceuticals Latest Developments
Table 105. Roche Basic Information, Chronic Hepatitis B Virus Testing Manufacturing Base, Sales Area and Its Competitors
Table 106. Roche Chronic Hepatitis B Virus Testing Product Portfolios and Specifications
Table 107. Roche Chronic Hepatitis B Virus Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Roche Main Business
Table 109. Roche Latest Developments
Table 110. Vir Biotechnology Basic Information, Chronic Hepatitis B Virus Testing Manufacturing Base, Sales Area and Its Competitors
Table 111. Vir Biotechnology Chronic Hepatitis B Virus Testing Product Portfolios and Specifications
Table 112. Vir Biotechnology Chronic Hepatitis B Virus Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Vir Biotechnology Main Business
Table 114. Vir Biotechnology Latest Developments
Table 115. Bio-Rad Laboratories, Inc. Basic Information, Chronic Hepatitis B Virus Testing Manufacturing Base, Sales Area and Its Competitors
Table 116. Bio-Rad Laboratories, Inc. Chronic Hepatitis B Virus Testing Product Portfolios and Specifications
Table 117. Bio-Rad Laboratories, Inc. Chronic Hepatitis B Virus Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Bio-Rad Laboratories, Inc. Main Business
Table 119. Bio-Rad Laboratories, Inc. Latest Developments
Table 120. DiaSorin S.p.A. Basic Information, Chronic Hepatitis B Virus Testing Manufacturing Base, Sales Area and Its Competitors
Table 121. DiaSorin S.p.A. Chronic Hepatitis B Virus Testing Product Portfolios and Specifications
Table 122. DiaSorin S.p.A. Chronic Hepatitis B Virus Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. DiaSorin S.p.A. Main Business
Table 124. DiaSorin S.p.A. Latest Developments
Table 125. Abbott Laboratories Basic Information, Chronic Hepatitis B Virus Testing Manufacturing Base, Sales Area and Its Competitors
Table 126. Abbott Laboratories Chronic Hepatitis B Virus Testing Product Portfolios and Specifications
Table 127. Abbott Laboratories Chronic Hepatitis B Virus Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Abbott Laboratories Main Business
Table 129. Abbott Laboratories Latest Developments
Table 130. Meridian Bioscience Basic Information, Chronic Hepatitis B Virus Testing Manufacturing Base, Sales Area and Its Competitors
Table 131. Meridian Bioscience Chronic Hepatitis B Virus Testing Product Portfolios and Specifications
Table 132. Meridian Bioscience Chronic Hepatitis B Virus Testing Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Meridian Bioscience Main Business
Table 134. Meridian Bioscience Latest Developments

LIST OF FIGURES

Figure 1. Picture of Chronic Hepatitis B Virus Testing
Figure 2. Chronic Hepatitis B Virus Testing Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chronic Hepatitis B Virus Testing Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Chronic Hepatitis B Virus Testing Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Chronic Hepatitis B Virus Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Chronic Hepatitis B Virus Testing Sales Market Share by Country/Region (2025)
Figure 10. Chronic Hepatitis B Virus Testing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Enzyme Immunoassay Kits
Figure 12. Product Picture of Hepatitis B Surface Antigen Test
Figure 13. Product Picture of Anti-Hepatitis B Surface Antibody Test
Figure 14. Product Picture of Anti-Hepatitis B Core Antibody Test
Figure 15. Product Picture of Point-of-Care Testing Kits
Figure 16. Global Chronic Hepatitis B Virus Testing Sales Market Share by Type in 2026
Figure 17. Global Chronic Hepatitis B Virus Testing Revenue Market Share by Type (2021-2026)
Figure 18. Chronic Hepatitis B Virus Testing Consumed in Hospitals
Figure 19. Global Chronic Hepatitis B Virus Testing Market: Hospitals (2021-2026) & (K Units)
Figure 20. Chronic Hepatitis B Virus Testing Consumed in Clinics
Figure 21. Global Chronic Hepatitis B Virus Testing Market: Clinics (2021-2026) & (K Units)
Figure 22. Chronic Hepatitis B Virus Testing Consumed in Diagnostic Centers
Figure 23. Global Chronic Hepatitis B Virus Testing Market: Diagnostic Centers (2021-2026) & (K Units)
Figure 24. Chronic Hepatitis B Virus Testing Consumed in Home
Figure 25. Global Chronic Hepatitis B Virus Testing Market: Home (2021-2026) & (K Units)
Figure 26. Global Chronic Hepatitis B Virus Testing Sale Market Share by Application (2025)
Figure 27. Global Chronic Hepatitis B Virus Testing Revenue Market Share by Application in 2026
Figure 28. Chronic Hepatitis B Virus Testing Sales by Company in 2026 (K Units)
Figure 29. Global Chronic Hepatitis B Virus Testing Sales Market Share by Company in 2026
Figure 30. Chronic Hepatitis B Virus Testing Revenue by Company in 2026 ($ millions)
Figure 31. Global Chronic Hepatitis B Virus Testing Revenue Market Share by Company in 2026
Figure 32. Global Chronic Hepatitis B Virus Testing Sales Market Share by Geographic Region (2021-2026)
Figure 33. Global Chronic Hepatitis B Virus Testing Revenue Market Share by Geographic Region in 2026
Figure 34. Americas Chronic Hepatitis B Virus Testing Sales 2021-2026 (K Units)
Figure 35. Americas Chronic Hepatitis B Virus Testing Revenue 2021-2026 ($ millions)
Figure 36. APAC Chronic Hepatitis B Virus Testing Sales 2021-2026 (K Units)
Figure 37. APAC Chronic Hepatitis B Virus Testing Revenue 2021-2026 ($ millions)
Figure 38. Europe Chronic Hepatitis B Virus Testing Sales 2021-2026 (K Units)
Figure 39. Europe Chronic Hepatitis B Virus Testing Revenue 2021-2026 ($ millions)
Figure 40. Middle East & Africa Chronic Hepatitis B Virus Testing Sales 2021-2026 (K Units)
Figure 41. Middle East & Africa Chronic Hepatitis B Virus Testing Revenue 2021-2026 ($ millions)
Figure 42. Americas Chronic Hepatitis B Virus Testing Sales Market Share by Country in 2026
Figure 43. Americas Chronic Hepatitis B Virus Testing Revenue Market Share by Country (2021-2026)
Figure 44. Americas Chronic Hepatitis B Virus Testing Sales Market Share by Type (2021-2026)
Figure 45. Americas Chronic Hepatitis B Virus Testing Sales Market Share by Application (2021-2026)
Figure 46. United States Chronic Hepatitis B Virus Testing Revenue Growth 2021-2026 ($ millions)
Figure 47. Canada Chronic Hepatitis B Virus Testing Revenue Growth 2021-2026 ($ millions)
Figure 48. Mexico Chronic Hepatitis B Virus Testing Revenue Growth 2021-2026 ($ millions)
Figure 49. Brazil Chronic Hepatitis B Virus Testing Revenue Growth 2021-2026 ($ millions)
Figure 50. APAC Chronic Hepatitis B Virus Testing Sales Market Share by Region in 2026
Figure 51. APAC Chronic Hepatitis B Virus Testing Revenue Market Share by Region (2021-2026)
Figure 52. APAC Chronic Hepatitis B Virus Testing Sales Market Share by Type (2021-2026)
Figure 53. APAC Chronic Hepatitis B Virus Testing Sales Market Share by Application (2021-2026)
Figure 54. China Chronic Hepatitis B Virus Testing Revenue Growth 2021-2026 ($ millions)
Figure 55. Japan Chronic Hepatitis B Virus Testing Revenue Growth 2021-2026 ($ millions)
Figure 56. South Korea Chronic Hepatitis B Virus Testing Revenue Growth 2021-2026 ($ millions)
Figure 57. Southeast Asia Chronic Hepatitis B Virus Testing Revenue Growth 2021-2026 ($ millions)
Figure 58. India Chronic Hepatitis B Virus Testing Revenue Growth 2021-2026 ($ millions)
Figure 59. Australia Chronic Hepatitis B Virus Testing Revenue Growth 2021-2026 ($ millions)
Figure 60. China Taiwan Chronic Hepatitis B Virus Testing Revenue Growth 2021-2026 ($ millions)
Figure 61. Europe Chronic Hepatitis B Virus Testing Sales Market Share by Country in 2026
Figure 62. Europe Chronic Hepatitis B Virus Testing Revenue Market Share by Country (2021-2026)
Figure 63. Europe Chronic Hepatitis B Virus Testing Sales Market Share by Type (2021-2026)
Figure 64. Europe Chronic Hepatitis B Virus Testing Sales Market Share by Application (2021-2026)
Figure 65. Germany Chronic Hepatitis B Virus Testing Revenue Growth 2021-2026 ($ millions)
Figure 66. France Chronic Hepatitis B Virus Testing Revenue Growth 2021-2026 ($ millions)
Figure 67. UK Chronic Hepatitis B Virus Testing Revenue Growth 2021-2026 ($ millions)
Figure 68. Italy Chronic Hepatitis B Virus Testing Revenue Growth 2021-2026 ($ millions)
Figure 69. Russia Chronic Hepatitis B Virus Testing Revenue Growth 2021-2026 ($ millions)
Figure 70. Middle East & Africa Chronic Hepatitis B Virus Testing Sales Market Share by Country (2021-2026)
Figure 71. Middle East & Africa Chronic Hepatitis B Virus Testing Sales Market Share by Type (2021-2026)
Figure 72. Middle East & Africa Chronic Hepatitis B Virus Testing Sales Market Share by Application (2021-2026)
Figure 73. Egypt Chronic Hepatitis B Virus Testing Revenue Growth 2021-2026 ($ millions)
Figure 74. South Africa Chronic Hepatitis B Virus Testing Revenue Growth 2021-2026 ($ millions)
Figure 75. Israel Chronic Hepatitis B Virus Testing Revenue Growth 2021-2026 ($ millions)
Figure 76. Turkey Chronic Hepatitis B Virus Testing Revenue Growth 2021-2026 ($ millions)
Figure 77. GCC Countries Chronic Hepatitis B Virus Testing Revenue Growth 2021-2026 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Chronic Hepatitis B Virus Testing in 2026
Figure 79. Manufacturing Process Analysis of Chronic Hepatitis B Virus Testing
Figure 80. Industry Chain Structure of Chronic Hepatitis B Virus Testing
Figure 81. Channels of Distribution
Figure 82. Global Chronic Hepatitis B Virus Testing Sales Market Forecast by Region (2027-2032)
Figure 83. Global Chronic Hepatitis B Virus Testing Revenue Market Share Forecast by Region (2027-2032)
Figure 84. Global Chronic Hepatitis B Virus Testing Sales Market Share Forecast by Type (2027-2032)
Figure 85. Global Chronic Hepatitis B Virus Testing Revenue Market Share Forecast by Type (2027-2032)
Figure 86. Global Chronic Hepatitis B Virus Testing Sales Market Share Forecast by Application (2027-2032)
Figure 87. Global Chronic Hepatitis B Virus Testing Revenue Market Share Forecast by Application (2027-2032)


More Publications